Jonathan S Weiss, MD, FAAD
SESSIONS
DISCLOSURES
AbbVie – Investigator(Grants/Research Funding), Speaker(Honoraria); Amore Pacific – Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Honoraria), Speaker(Honoraria); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Fees); Biofrontera – Consultant(Fees), Investigator(Grants/Research Funding); Cutera, Inc. – Consultant(Honoraria); Dermavant Sciences – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Speaker(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis – Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria), Speaker(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Palvella Therapeutics – Investigator(Grants/Research Funding); Regeneron – Speaker(Honoraria); Sagimet Biosciences – Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees); VeraDermics Inc. – Consultant (1099 relationship)(Fees); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);